BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Small Cap Pro

1 year 30%, 2 years 40% and *3 years 50%

*Across 3 years $2158.56 only $1079.28

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,019.77
      0.35%
      US Tech 100
      20,282.40
      0.35%
      Dow Jones
      44,834.88
      0.25%
      Brent Oil
      73.14
      0.64%
      Bitcoin
      98,094.82
      2.55%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Pharming Group NV (PHAR)

      7. Pharming Group NV (PHAR) Financials

      Pharming Group NV

      Pharming Group NV (PHAR)

      Pharos Energy Plc
      7.74
      0.165
      ( 2.18% )
      Updated: 09:38:51
      Delayed by 15 minutes

      Pharming Group NV Financial Summary

      The current PHAR market cap is 519.41M. The company's latest EPS is USD -0.1572 and P/E is -4.64.

      Income Statement

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      EUR (€)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 66.66M81.22M55.59M74.09M74.85M
      Operating Income 1.42M-30.12M-16.85M-3.42M3.67M
      Net Income 3.46M-2.69M-12.45M-1.22M-1.03M
      Year End December 30 2023 20192020202120222023
      EUR (€)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 169.02M212.17M198.87M205.62M245.32M
      Operating Income 61.14M76.62M14.26M17.09M-5.68M
      Net Income 36.2M37.75M16M13.67M-10.55M

      Balance Sheet

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      EUR (€)USD ($)USD ($)USD ($)USD ($)
      Total Assets 436.47M461.42M441.67M415.93M425.51M
      Total Liabilities 226.53M242.24M235.72M194.99M199.72M
      Total Equity 209.94M219.19M205.95M220.94M225.79M
      Year End December 30 2023 20192020202120222023
      EUR (€)USD ($)USD ($)USD ($)USD ($)
      Total Assets 228.21M418.45M397.32M425.8M462.85M
      Total Liabilities 123.53M235.02M204.4M221.16M244.07M
      Total Equity 104.68M183.44M192.92M204.64M218.78M

      Cash Flow

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      EUR (€)USD ($)USD ($)USD ($)USD ($)
      Operating -28.88M-17.52M-7.65M-20.87M9.74M
      Investing -125.48M-129.39M664k37.06M4.35M
      Financing -19k-1.04M-2.47M-30.78M-1.43M
      Year End December 30 2023 20192020202120222023
      EUR (€)USD ($)USD ($)USD ($)USD ($)
      Operating 66.5M83.63M37.84M22.46M-17.3M
      Investing -25.22M-15.63M-21.31M5.32M-129.39M
      Financing -56.65M60.69M-27.95M-4.98M-1.04M

      Stats and Ratios

      Market Cap 519.41M
      Price to Earnings Ratio -4.64
      Price to Sales Ratio 0.2
      Price to Cash Ratio 0.79
      Price to Book Ratio 0.22
      Dividend Yield -

      Share Statistics

      Shares Outstanding 67.11M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 0.23 (2.94%)

      Company Info

      Company Name Pharming Group NV
      Address vondellaan 47
      leiden, south holland 2332 AA
      Website https://www.pharming.com
      Industry pharmaceutical diversified (H2)

      Your Recent History

      NASDAQ
      PHAR
      Pharming Group NV
      Delayed Upgrade Clock